Brief: NeuBase Therapeutics Receives Notification Of Deficiency From Nasdaq Related To Delayed Quarterly Report On Form 10-Q
21/02/2020 21:56
Feb 21 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS RECEIVES NOTIFICATION OF DEFICIENCY
FROM
NASDAQ RELATED TO DELAYED QUARTERLY REPORT ON FORM 10-Q
* NEUBASE THERAPEUTICS INC - EXPECTS TO FILE ITS FORM 10-Q
FOR
PERIOD ENDED DECEMBER 31, 2019 BY END OF MARCH 2020.
Source text for Eikon: ID:nGNX1gQm1q
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet